Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How useful is [123I]beta-CIT SPECT in clinical practice?

J Eerola1, P J Tienari, S Kaakkola

  • 1Department of Neurology, HUCH, PO Box 340, FIN-00029 HUS, Helsinki, Finland. johanna.eerola@hus.fi

Journal of Neurology, Neurosurgery, and Psychiatry
|August 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HLA-Region Genetic Association Analysis of Breast Cancer Patients With and Without Persistent Postsurgical Neuropathic Pain.

European journal of pain (London, England)·2025
Same author

Frequency and risk factors of rebound after fingolimod discontinuation - A retrospective study.

Multiple sclerosis and related disorders·2023
Same author

Primary familial brain calcification linked to deletion of 5' noncoding region of SLC20A2.

Acta neurologica Scandinavica·2016
Same author

Intrafamilial clinical variability in individuals carrying the CHCHD10 mutation Gly66Val.

Acta neurologica Scandinavica·2015
Same author

Entacapone in combination with standard or controlled-release levodopa/carbidopa: a clinical and pharmacokinetic study in patients with Parkinson's disease.

European journal of neurology·2013
Same author

Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis.

Genes and immunity·2009
Same journal

Global epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Diagnostic accuracy of a two-cut-off approach using the FAQ/MMSE ratio and FAQ for clinical preselection of patients for anti-amyloid therapy.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Visuospatial working memory in Huntington's disease: behavioural and structural brain correlates.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Characteristics and outcomes in electric scooter-related traumatic brain injuries in Helsinki.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal of neurology, neurosurgery, and psychiatry·2026
See all related articles

[(123)I]beta-CIT SPECT shows high accuracy for diagnosing Parkinson's disease in younger patients. However, its diagnostic usefulness decreases in older patients due to overlapping results with other parkinsonian syndromes.

Area of Science:

  • Neurology
  • Nuclear Medicine
  • Radiopharmacology

Background:

  • Parkinson's disease (PD) diagnosis relies on clinical symptoms, but differentiation from other parkinsonian syndromes can be challenging.
  • [(123)I]beta-CIT SPECT, a dopamine transporter imaging agent, has been explored for its diagnostic utility.

Purpose of the Study:

  • To evaluate the accuracy and clinical utility of [(123)I]beta-CIT SPECT in distinguishing Parkinson's disease from other movement disorders.

Main Methods:

  • 185 patients with movement disorders underwent [(123)I]beta-CIT SPECT.
  • Diagnoses included Parkinson's disease, essential tremor, vascular parkinsonism, Parkinson plus syndromes (P+), dementia with Lewy bodies (DLB), and drug-induced movement disorders.
  • A reference group of 20 subjects with psychogenic parkinsonism was included.

Related Experiment Videos

Main Results:

  • [(123)I]beta-CIT uptake was significantly lower in Parkinson's disease patients compared to essential tremor, dystonia, and drug-induced movement disorders.
  • Vascular parkinsonism showed heterogeneous uptake, falling between the reference and PD groups.
  • P+ and DLB groups exhibited striatal uptake overlapping with the Parkinson's disease group.

Conclusions:

  • [(123)I]beta-CIT SPECT demonstrated 100% sensitivity and specificity for Parkinson's disease in patients under 55 years old.
  • Specificity decreased to 68.5% in patients over 55 years old.
  • The reduced specificity in older patients is attributed to the different distribution of differential diagnostic disorders in this age group.